Research and Development

Biotech pioneer Amgen has sold off two niche products to Biovitrum, along with the promotional rights to a third product, …

Merck Serono has agreed to take on full responsibility for developing a promising antibody from its partner ZymoGenetics. The German …

Top oncology specialists across Holland, France and Sweden have formed a new alliance to improve cancer research and reduce treatment …

Attention shifts from beta-amyloid to tau in the hunt for an Alzheimer's disease therapyIn years to come, scientists and pharmaceutical …

 Martin Dawkins is an Englishman born and bred, but has spent most of his career working abroad, including the US, …

Pfizer: changes in R&D structure expected to increase number of late stage productsPharmaceutical giant Pfizer has announced that it intends …

Five British medical research centres and hospitals have come together to create a new academic health science partnership, the largest …

This year is a bit of a jamboree of health-related anniversaries, with the NHS celebrating 60 years and the Medicines …

Parexel has finalised its acquisition of ClinPhone after rivals Quintiles dropped out of the race for the clinical technology firm. …

 AstraZeneca has signed a deal to work with Singapore’s National Cancer Centre and National University Hospital to develop new cancer …

Bayer Schering Pharma has acquired two potential cancer drugs and a range of oncology compounds from Nycomed in a deal …

Biovest/Accentia's BiovaxID revives hope for therapeutic cancer vaccines Biovest, a subsidiary of Accentia, has announced positive data from a pivotal …

In the headlong race for global domination, pharma companies are in the process of flattening their hierarchies, slashing bureaucracy, streamlining …